[Observations on the subject of clinical experimentation of a new synthetic antianginal compound: N-3'-phenyl-propyl-(2')-1,1-diphenyl-propyl-(3)-amine].
D000588:Amines; D001713:Biphenyl Compounds; D002317:Cardiovascular Agents; D006801:Humans; D011299:Prenylamine; D012107:Research Design
D000588:Amines; D001713:Biphenyl Compounds; D002317:Cardiovascular Agents; D011299:Prenylamine; C010574:biphenyl
SEGONTIN